North Macedonia vs Paraguay: Share of people with HIV who receive antiretroviral therapy
North Macedonia
59.0%
in 2024
Paraguay
58.0%
in 2024
North Macedonia rank
109th
Paraguay rank
110th
Share of people with HIV who receive antiretroviral therapy over time
- North Macedonia
- Paraguay
How they compare
North Macedonia currently reports 59.0% against 58.0% in Paraguay, a difference of 1.0%.
The two have swapped places 8 times across 25 shared years of data; in 2000 it was North Macedonia ahead.
North Macedonia ranks 109th and Paraguay ranks 110th of 143 countries.
Across the 3 decades both report, North Macedonia averaged higher in 1 and Paraguay in 1.
Head to head by decade
| Decade | North Macedonia | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.1% | 6.7% | 4.4% | North Macedonia |
| 2010s | 34.8% | 35.8% | 1.0% | Paraguay |
| 2020s | 54.6% | 54.6% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, North Macedonia or Paraguay?
- North Macedonia, at 59.0% against 58.0% in Paraguay as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between North Macedonia and Paraguay?
- 1.0%, with North Macedonia ahead.
- How many years of comparable data are there for North Macedonia and Paraguay?
- 25 years are reported by both, from 2000 to 2024.
- How do North Macedonia and Paraguay rank globally for share of people with hiv who receive antiretroviral therapy?
- North Macedonia ranks 109th and Paraguay ranks 110th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.